Search

Reliance Pharma Fund Unrated

Value Research
1.51%
Change from previous, NAV as on Aug 24, 2016
Category: Equity: Pharma
Assets: R 1,539 crore (As on Jul 31, 2016)
Expense: 2.15% (As on Jul 31, 2016)
SUBSCRIBE TO THE VALUE RESEARCH FUNDLINE NEWSLETTER
Investment Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

Fund Managers
+ Sailesh Raj Bhan since Mar 2005
comments powered by Disqus